USC Schaeffer Center’s Article on COVID-19 Vaccination Campaign USC Schaeffer Center’s Article on COVID-19 Vaccination Campaign
  • Home
  • About Us
  • Technology
  • News
    • Media Coverage
    • Press Releases
  • Contact Us
Menu
  • Home
  • About Us
  • Technology
  • News
    • Media Coverage
    • Press Releases
  • Contact Us

Uncategorized

USC Schaeffer Center’s Article on COVID-19 Vaccination Campaign

The USC Schaeffer Center for Health Policy & Economics, in collaboration with Brown University, has produced an exceptionally insightful article that brilliantly encapsulates the monumental benefits of vaccines in the battle against the COVID-19 pandemic. This comprehensive study, which reveals that the global vaccination effort saved an estimated 2.4 million lives across 141 countries, serves as a resounding testament to the efficacy and critical importance of vaccines.

By providing a detailed analysis of the health and economic impacts, the article not only highlights the immediate life-saving potential of the vaccines but also emphasizes the significant economic benefits, valuing the lives saved at a staggering $6.5 trillion.

Moreover, the article effectively contrasts the success of vaccines with other non-pharmaceutical interventions, such as lockdowns and mask mandates, offering a clear perspective on the unparalleled role vaccines played in curbing the pandemic’s toll. The meticulous research and clear presentation in this article make it an indispensable resource for understanding the true scope and success of the global COVID-19 vaccination campaign.

COVID-19-Vaccination-Campaign-Saved-2.4-Million-Lives-–-USC-Schaeffer-1Download
COVID-19 Vaccination Campaign Saved 2.4 Million Lives

Read More

Recent Posts

  • TechImmune’s Research Referenced in Nature: Quest for a Next-Generation Pan-Coronavirus VaccineAugust 20, 2024
  • High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patientsMay 2, 2024
  • What’s next for COVID vaccines?February 9, 2024
  • TechImmune to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceJanuary 3, 2024
  • USC Schaeffer Center’s Article on COVID-19 Vaccination CampaignNovember 28, 2023
© 2022 TechImmune, LLC. All rights reserved.
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
  • Disclaimer
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}